Investors who lost money on ModivCare Inc.(MODV) should contact The Gross Law Firm about pending Class Action - MODV — Neutral
MODV PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ModivCare Inc. (NASDAQ: MODV). Shareholders who purchased shares of MODV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm Reminds TELUS International (Cda) Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 31, 2025 - TIXT — Neutral
TIXT PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of TELUS International (Cda) Inc. (NYSE: TIXT). Shareholders who purchased shares of TIXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 - NVO — Neutral
NVO PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Lost Money on Capri Holdings Limited(CPRI)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm — Neutral
CPRI PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Capri Holdings Limited (NYSE: CPRI). Shareholders who purchased shares of CPRI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Investors in Transocean Ltd. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - RIG — Neutral
RIG PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Transocean Ltd. (NYSE: RIG).
Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before February 10, 2025 to Discuss Your Rights - SAVA — Neutral
SAVA PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cassava Sciences, Inc. (NASDAQ: SAVA). Shareholders who purchased shares of SAVA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 14, 2025 in MGP Ingredients, Inc. Lawsuit - MGPI — Neutral
MGPI PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of MGP Ingredients, Inc. (NASDAQ: MGPI). Shareholders who purchased shares of MGPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Joint Stock Company Kaspi.kz Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - KSPI — Neutral
KSPI PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Joint Stock Company Kaspi.kz (NASDAQ: KSPI). Shareholders who purchased shares of KSPI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Investors who lost money on AstraZeneca PLC(AZN) should contact The Gross Law Firm about pending Class Action - AZN — Neutral
AZN PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of AstraZeneca PLC (NASDAQ: AZN). Shareholders who purchased shares of AZN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Investors in Nextracker Inc. Should Contact The Gross Law Firm Before February 25, 2025 to Discuss Your Rights - NXT — Neutral
NXT PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Nextracker Inc. (NASDAQ: NXT). Shareholders who purchased shares of NXT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Revance Therapeutics, Inc.(RVNC) Shareholders — Neutral
RVNC PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Revance Therapeutics, Inc. (NASDAQ: RVNC). Shareholders who purchased shares of RVNC during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm Notifies Regeneron Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - REGN — Neutral
REGN PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). Shareholders who purchased shares of REGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Shareholders that lost money on Caribou Biosciences, Inc.(CRBU) should contact The Gross Law Firm about pending Class Action - CRBU — Neutral
CRBU PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU). Shareholders who purchased shares of CRBU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
GSK plc Class Action: The Gross Law Firm Reminds GSK Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - GSK — Neutral
GSK PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of GSK plc (NYSE: GSK). Shareholders who purchased shares of GSK during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT — Neutral
APLT PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT). Shareholders who purchased shares of APLT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Micron Technology, Inc. Class Action: The Gross Law Firm Reminds Micron Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - MU — Neutral
MU PRNewsWire — February 10, 2025NEW YORK , Feb. 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Micron Technology, Inc. (NASDAQ: MU). Shareholders who purchased shares of MU during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment.
Prediction: These 2 Vanguard ETFs Will Trounce the S&P 500 This Year — Positive
VFH VOO VOOG The Motley Fool — February 10, 2025Many Wall Street analysts think the S&P 500 will rise for the third consecutive year in 2025. Projections vary, but the consensus forecast appears to be that the index could jump in the ballpark of 10%.
Akebia Therapeutics: Still Bullish On Vafseo As Auryxia's Revenues Decline — Positive
AKBA Seeking Alpha — February 10, 2025Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia's declining revenues from patent expiration. Vafseo is now approved for dialysis patients and leverages AKBA's signature HIF pathway. So far, it has shown some early successes, which makes me optimistic. AKBA is also working on a Phase 3 trial for non‑dialysis CKD patients, which is scheduled for mid‑2025 to support a potential label expansion.
SoFi Technologies: Maintaining Strong Buy On Macro Tailwinds — Positive
SOFI Seeking Alpha — February 10, 2025Delinquency rate growth is continuing to slow, creating a positive operating environment for SoFi. Refinancing demand exists, and SoFi is ready to capture the demand through its continued member growth and flywheel strategy. Despite about 100% stock price appreciation in recent months, I continue to believe that the company is reasonably valued.
This Fintech Sold Off Hard After Earnings, But It's Primed For A Big 2025 — Positive
LC The Motley Fool — February 10, 2025Popular market analyst Tom Lee of Fundstrat recently called the financial sector his favorite investment for 2025.
